USPTO Examiner CARTER TARA ROSE E - Art Unit 3773

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19278532INTERVERTEBRAL MEMBERS AND METHODS OF USING A BONE REINFORCING COMPOSITION FOR RETAINING THE INTERVERTEBRAL MEMBERSJuly 2025March 2026Allow811YesNo
19234723ANCHOR DEVICE FOR BONE IMPLANTATION DURING SURGICAL PROCEDURESJune 2025November 2025Allow520YesNo
19234810ANCHOR DEVICE FOR BONE IMPLANTATION DURING SURGICAL PROCEDURESJune 2025December 2025Allow610YesNo
18943017Surgical Retractor, Methods of Making a Surgical Retractor, and Methods of Retracting TissueNovember 2024January 2026Allow1500NoNo
18910337ANCHOR DEVICE FOR BONE IMPLANTATION DURING SURGICAL PROCEDURESOctober 2024April 2025Allow611YesNo
18840992PHALANX FRACTURE REDUCTIONAugust 2024August 2025Allow1200NoNo
18807223Pedicle Fusion DeviceAugust 2024June 2025Allow1011YesNo
18789143Surgical Elevator OximeterJuly 2024February 2026Allow1910NoNo
18767832Surgical Elevator OximeterJuly 2024February 2026Allow2010NoNo
18746748MODULAR SPINAL FIXATION SCREWJune 2024October 2024Allow310NoNo
18742786SURGICAL SYSTEM INCLUDING POWERED ROTARY-TYPE HANDPIECEJune 2024February 2026Allow2010NoNo
18740176SURGICAL AND STABILIZATION TECHNIQUES FOR TREATMENT OF SACROILIAC JOINTSJune 2024March 2025Allow910NoNo
18675339ACCESS PORT TO INSUFFLATE THE ABDOMEN FOR LAPAROSCOPIC SURGERYMay 2024November 2025Allow1811YesNo
18669966REMOTE MEDICAL EXAMINATIONMay 2024July 2025Allow1410NoNo
18662400DEVICES, METHODS AND SYSTEMS FOR REMEDYING OR PREVENTING FRACTURESMay 2024August 2025Allow1510NoNo
18655627RETROGRADE FEMORAL INTRAMEDULLARY NAIL, AND RELATED SYSTEMS AND METHODSMay 2024July 2025Allow1520NoNo
18650493REMOTE MEDICAL EXAMINATIONApril 2024July 2025Allow1410NoNo
18649200SCOPEApril 2024July 2025Allow1510NoNo
18643397ENDOLUMINAL DEVICE WITH RETRACTOR SYSTEMApril 2024June 2025Allow1410NoNo
18639386Spinal ImplantApril 2024April 2025Allow1210YesNo
18636685ILLUMINATING EYE DEPRESSORApril 2024January 2026Allow2111YesNo
18635281Surgical RetractorApril 2024March 2026Allow2310NoNo
18617035MEDICAL IMPLANT FOR FIXATION AND INTEGRATION WITH HARD TISSUEMarch 2024May 2025Allow1310NoNo
18608287SLEEVE FOR SPECULUM AND USE THEREOFMarch 2024January 2025Allow1000NoNo
18444925TISSUE-SPREADER ASSEMBLYFebruary 2024August 2025Allow1820NoNo
18408281INTERBODY FUSION DEVICES AND RELATED METHODS OF MANUFACTUREJanuary 2024January 2025Allow1210NoNo
18406806ARTICULATING STABILIZER ARM WITH DISPOSABLE AND REUSABLE SUBASSEMBLIESJanuary 2024February 2025Allow1310NoNo
18406163Retraction System for Maxillofacial SurgeryJanuary 2024February 2026Abandon2510NoNo
18569849CLAMPING TOOL MOUNTED REGISTRATION MARKER FOR ORTHOPEDIC SURGICAL PROCEDURESDecember 2023November 2025Allow2310NoNo
18532566Implant Design Optimization for Geometric UncertaintyDecember 2023November 2025Allow2310NoNo
18530003DEVICE FOR ATRAUMATIC PASSAGEWAY OF INSTRUMENTS WITH OR WITHOUT DILATIONDecember 2023August 2025Allow2110NoNo
18526766TRANSNASAL ODONTOID RETRACTORDecember 2023March 2025Allow1510NoNo
18514825Spinal Stability SystemNovember 2023March 2024Allow410NoNo
18509963SENSOR ENABLED RETRACTOR FOR ROBOTIC SURGERYNovember 2023February 2025Allow1510NoNo
18503455UNILATERAL IMPLANT HOLDERS AND RELATED METHODSNovember 2023February 2025Allow1610NoNo
18387280Set Screw for Femoral NailNovember 2023March 2025Allow1610YesNo
18497922Spinal Stability System with Expandable CannulaOctober 2023March 2025Allow1610NoNo
18487951SURGICAL SPACE MAKER DEVICEOctober 2023October 2025Allow2411YesNo
18380543DEVICES AND METHODS FOR VERTEBRAL BONE REALIGNMENTOctober 2023October 2025Abandon2410NoNo
18377536Adjustable Triple Heads Thyroid RetractorOctober 2023July 2024Allow920NoNo
18371773Systems and Methods for Internal Bone FixationSeptember 2023March 2025Allow1810NoNo
18462813WOUND RETRACTOR AND DIFFUSERSeptember 2023March 2025Allow1910NoNo
18242633DYNAMIC AND NON-DYNAMIC INTERSPINOUS FUSION IMPLANT AND BONE GROWTH STIMULATION SYSTEMSeptember 2023April 2025Allow1910NoNo
18239206METHOD AND APPARATUS FOR SPINAL FACET FUSIONAugust 2023May 2025Allow2010NoNo
18455681RING HOLE PLANNING FOR EXTERNAL FIXATION FRAMESAugust 2023December 2024Allow1510NoNo
18278727SURGICAL RETRACTOR DEVICEAugust 2023May 2025Allow2100NoNo
18452830EXPANDABLE INTRAMEDULLARY SYSTEMS AND METHODS OF USING THE SAMEAugust 2023January 2025Allow1710NoNo
17996317CONNECTING APPARATUS FOR CONNECTING PINS AND/OR ROD ELEMENTS OF AN EXTERNAL FIXATOR, EXTERNAL FIXATOR, AND DEVICE FOR OUTPATIENT EMERGENCY CAREAugust 2023March 2026Allow4110NoNo
18449427PIVOTAL BONE ANCHOR ASSEMBLY WITH CANNULATED SHANK HAVING A PLANAR TOP SURFACE AND METHOD OF ASSEMBLYAugust 2023May 2024Allow910NoNo
18447054Retractor Blade Devices and Related MethodsAugust 2023January 2025Allow1710NoNo
18347152EXPANDABLE BI-DIMENSIONAL INTERBODY AND METHOD OF MANUFACTURING THE SAMEJuly 2023April 2025Abandon2110NoNo
18343799MULTIPLE TRACK SYSTEM FOR POSITIONING OF BONE SEGMENTSJune 2023May 2025Allow2310NoNo
18213121RETRACTION SYSTEMS, ASSEMBLIES, AND DEVICESJune 2023January 2025Allow1910NoNo
18337971COOPERATIVE ACCESS HYBRID PROCEDURESJune 2023June 2025Allow2420NoNo
18267481LAPAROSCOPIC TISSUE CONTAINMENT DEVICEJune 2023December 2025Allow3010NoNo
18209162TISSUE MANIPULATION DEVICEJune 2023April 2025Allow2200NoNo
18265383MODULAR PIEZOELECTRIC INTERMEDULLARY NAILJune 2023September 2025Allow2710NoNo
18204597SURGICAL RETRACTORJune 2023August 2024Allow1400NoNo
18318009REDUCTION INSTRUMENTS AND METHODSMay 2023December 2024Allow1910NoNo
18139750Dynamic Nail-Plate CombinationApril 2023February 2026Allow3420NoNo
18301728IMPLANT RECEIVERS AND CONNECTORS WITH GRIP GROOVES FOR ROD FIXATIONApril 2023October 2024Allow1810NoNo
18301296EXPANDABLE INTERVERTEBRAL IMPLANTApril 2023July 2024Allow1500NoNo
18193106Intracorporeal Retracting SutureMarch 2023August 2025Allow2810NoNo
18127548MOUTHPIECEMarch 2023October 2025Allow3010NoNo
18183739EXPANDABLE VERTEBRAL BODY REPLACEMENT DEVICE AND METHODMarch 2023October 2024Allow1910NoNo
18107291DEVICES, SYSTEMS, AND METHODS FOR TISSUE TRACTIONFebruary 2023October 2025Allow3310YesNo
18107222TISSUE TRACTION DEVICES, SYSTEMS, AND METHODS, AND DEVICES, SYSTEMS, AND METHODS FOR DELIVERY THEREOFFebruary 2023August 2025Allow3010NoNo
18103041CONVERTIBLE SURGICAL ACCESS PORTJanuary 2023August 2024Allow1910NoNo
18158248MINIMALLY INVASIVE POSTERIOR CERVICAL FACET ARTHRODESIS SHIM IMPLANT AND TOOLS THEREFORJanuary 2023July 2024Allow1810NoNo
18151137ORTHOPEDIC CLAMP AND EXTENSION RODJanuary 2023September 2024Allow2010NoNo
18150502SPINAL ALIGNMENT FRAMEJanuary 2023August 2024Allow2010NoNo
18087738Spinal Stability SystemDecember 2022July 2023Allow711YesNo
18082103RETRACTOR INTRODUCER SYSTEMSDecember 2022July 2025Allow3110NoNo
18076379BONE ANCHOR HEAD EXTENDERDecember 2022October 2024Allow2210NoNo
18058589IMPLANT HAVING A SHAFT COATED WITH A WEB STRUCTURENovember 2022December 2024Allow2410NoNo
17982447POLYAXIAL PEDICLE SCREW SYSTEMNovember 2022December 2024Abandon2510NoNo
18052260PLIF HINGED SPACERNovember 2022August 2024Allow2210NoNo
17968660SURGICAL ACCESS DEVICE WITH FIXATION MECHANISM AND ILLUMINATION MECHANISMOctober 2022August 2024Allow2210NoNo
18047038DEVICE FOR INSPECTING A CAVITY OF A PATIENTOctober 2022July 2025Allow3310NoNo
18047035DEVICE FOR INSPECTING A CAVITY OF A PATIENTOctober 2022July 2025Allow3310NoNo
17918473SCREWLESS INTERBODY DEVICE FOR SPINAL SURGERYOctober 2022September 2025Abandon3520NoNo
17959283EXPANDABLE IMPLANTOctober 2022August 2024Allow2210NoNo
17933871EXPANDABLE FUSION DEVICES AND METHODS OF INSTALLATION THEREOFSeptember 2022August 2024Allow2310NoNo
17945838METHOD AND APPARATUS FOR PERCUTANEOUS SURGICAL OPERATIONSSeptember 2022March 2024Allow1830NoNo
17945819TISSUE MANIPULATION DEVICESeptember 2022August 2023Allow1100NoNo
17909059Set Screw for Femoral NailSeptember 2022August 2023Allow1210YesNo
17909108Set Screw for Femoral NailSeptember 2022September 2024Allow2510YesNo
17895931SELF-RETAINING MEDICAL RETRACTOR TO FACILITATE SURGICAL PROCEDURES AND INSPECTIONAugust 2022February 2024Allow1810NoNo
17821238MIS CROSS-CONNECTORAugust 2022September 2024Allow2510NoNo
17819714POST-OPERATIVELY ADJUSTABLE ANGLED RODAugust 2022July 2024Allow2310NoNo
17818490RETRACTORAugust 2022August 2025Allow3610YesNo
17880062EXPANDABLE DEVICES, SYSTEMS, AND METHODSAugust 2022May 2024Allow2220NoNo
17816964Surgical retractor for cardiac surgeryAugust 2022June 2023Allow1100NoNo
17878780PIVOTAL BONE ANCHOR ASSEMBLY WITH PRELOADED ARTICULATING RETAINER AND BOTTOM LOADED SHANKAugust 2022April 2023Allow810NoNo
17794449HEIGHT-ADJUSTABLE SPINAL FUSION CAGEJuly 2022February 2025Allow3110NoNo
17810436Medical Device Probe and ConnectorJuly 2022July 2024Allow2510NoNo
17849899SURGICAL SYSTEM AND METHOD FOR TREATING VERTEBRAL SEGMENTS WITH UNEVEN PEDICLESJune 2022June 2023Allow1210NoNo
17845775VARIABLE/SELF-SECURING EAR SPECULUMJune 2022December 2025Abandon4210NoNo
17845065EXTERNAL FIXATION STRUTJune 2022May 2024Allow2310NoNo
17806595SPINOUS PROCESS PLATE FIXATION ASSEMBLYJune 2022July 2024Allow2510NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CARTER, TARA ROSE E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
2
(50.0%)
Examiner Reversed
2
(50.0%)
Reversal Percentile
79.2%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
20
Allowed After Appeal Filing
7
(35.0%)
Not Allowed After Appeal Filing
13
(65.0%)
Filing Benefit Percentile
57.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 35.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner CARTER, TARA ROSE E - Prosecution Strategy Guide

Executive Summary

Examiner CARTER, TARA ROSE E works in Art Unit 3773 and has examined 351 patent applications in our dataset. With an allowance rate of 84.0%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner CARTER, TARA ROSE E's allowance rate of 84.0% places them in the 59% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by CARTER, TARA ROSE E receive 2.13 office actions before reaching final disposition. This places the examiner in the 57% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by CARTER, TARA ROSE E is 30 months. This places the examiner in the 62% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +1.1% benefit to allowance rate for applications examined by CARTER, TARA ROSE E. This interview benefit is in the 19% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 26.5% of applications are subsequently allowed. This success rate is in the 44% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 57.8% of cases where such amendments are filed. This entry rate is in the 84% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 22% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 80.0% of appeals filed. This is in the 73% percentile among all examiners. Of these withdrawals, 25.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 68.5% are granted (fully or in part). This grant rate is in the 76% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.1% of allowed cases (in the 69% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 48% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.